Market Overview:
The global Burkitt lymphoma therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Burkitt lymphoma, rising awareness about available treatment options, and growing demand for novel therapies. The global Burkitt lymphoma therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into advanced dressing, biologics, traditional burn care products, and others. Advanced dressing held a major share of the global Burkitt lymphoma therapeutics market in 2017 owing to their ability to provide better patient outcomes than traditional dressings. Biologics are expected to be one of the fastest-growing segments during the forecast period due to their high efficacy and safety profile.
Product Definition:
Burkitt lymphoma therapeutics are used to treat Burkitt lymphoma, a type of cancer that affects the immune system. The importance of Burkitt lymphoma therapeutics is that they can help to improve the quality of life for those affected by this type of cancer.
Advanced Dressing:
Advanced dressing is a technique of wound care management that involves the application of a sterile, moist environment with an occlusive dressing over the wound. The advanced dressing helps in maintaining moisture around the wound and also provides protection against infections. Advanced dressings are used for chronic wounds such as diabetic foot ulcers, pressure ulcers and other slow healing wounds.
Biologics:
Biologics are living organisms or medicines derived from living organisms. They are either manufactured by extraction of the active ingredients from a single source, such as bacteria or yeast, or they are synthesized in laboratories using complex procedures. Biologics can be further classified into two types: monoclonal antibodies and recombinant proteins.
Application Insights:
The others segment held the largest share of the application market in 2017. This segment includes travel medicine and immunotherapy centers. The Burkitt lymphoma treatment guidelines recommend that patients with advanced disease be treated at hospitals or cancer clinics that offer high-quality services, as these facilities have a better track record for providing effective care to patients suffering from this condition. As a result, hospitals dominated the overall market in terms of revenue share in 2017.
However, due to increasing awareness about access to quality healthcare among people living outside major cities and rural areas across developing countries such as India and China, clinics are expected to witness lucrative growth over the forecast period owing to their growing penetration rate among people diagnosed with this condition.
Regional Analysis:
The market in the Middle East and Africa is anticipated to grow at a lucrative rate over the forecast period owing to increasing awareness about Burkitt Lymphoma, rising disposable income, and presence of key players in this region. Moreover, high prevalence of infectious diseases such as Ebola Virus Disease (EVD) is also expected to drive regional growth during the forecast period.
Key Companies: Johnson & Johnson Services Inc.; Pfizer; Merck Group; Bristol-Myers Squibb Company; AbbVie Inc.; Celgene Corporation; New York-Presbyterian Hospital Weill Cornell Medical Center Foundation LLC (NYP); Novartis AG; F. Hoffmann-La Roche AG & Co., Ltd.; Gilead Sciences, Inc.; Janssen Pharmaceutica N.V.
Growth Factors:
- Increasing incidence of Burkitt lymphoma
- Growing demand for novel and targeted therapies for the treatment of cancer
- Rising awareness about Burkitt lymphoma and its treatment options
- Technological advancements in the field of oncology therapies
- Availability of government funding for research and development activities in oncology
Scope Of The Report
Report Attributes
Report Details
Report Title
Burkitt Lymphoma Therapeutics Market Research Report
By Type
Advanced Dressing, Biologics, Traditional Burn Care Products, Others
By Application
Hospitals, Clinics, Others
By Companies
Takeda, Avita Medical, Smith＆Nephew, Coloplast Group, Systagenix Wound Management, MölnlyckeHealthCare, ConvaTec, Osiris Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Burkitt Lymphoma Therapeutics Market Report Segments:
The global Burkitt Lymphoma Therapeutics market is segmented on the basis of:
Types
Advanced Dressing, Biologics, Traditional Burn Care Products, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Takeda
- Avita Medical
- Smith＆Nephew
- Coloplast Group
- Systagenix Wound Management
- MölnlyckeHealthCare
- ConvaTec
- Osiris Therapeutics
Highlights of The Burkitt Lymphoma Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Advanced Dressing
- Biologics
- Traditional Burn Care Products
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Burkitt Lymphoma Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Burkitt Lymphoma Therapeutics is a biotechnology company focused on the development of novel therapeutics for Burkitt lymphoma. The company's lead product candidate, bortezomib, is in Phase III clinical trials for the treatment of Burkitt lymphoma.
Some of the major players in the burkitt lymphoma therapeutics market are Takeda, Avita Medical, Smith¯Â¼â€ Nephew, Coloplast Group, Systagenix Wound Management, MƒÂ¶lnlyckeHealthCare, ConvaTec, Osiris Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Burkitt Lymphoma Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Burkitt Lymphoma Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Burkitt Lymphoma Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Burkitt Lymphoma Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Burkitt Lymphoma Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Burkitt Lymphoma Therapeutics Market Size and Y-o-Y Growth
4.5.2 Burkitt Lymphoma Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Burkitt Lymphoma Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Burkitt Lymphoma Therapeutics Market Size Forecast by Type
5.2.1 Advanced Dressing
5.2.2 Biologics
5.2.3 Traditional Burn Care Products
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Burkitt Lymphoma Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Burkitt Lymphoma Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Burkitt Lymphoma Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Burkitt Lymphoma Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Burkitt Lymphoma Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Burkitt Lymphoma Therapeutics Market Size Forecast by Type
9.6.1 Advanced Dressing
9.6.2 Biologics
9.6.3 Traditional Burn Care Products
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Burkitt Lymphoma Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Burkitt Lymphoma Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Burkitt Lymphoma Therapeutics Market Size Forecast by Type
10.6.1 Advanced Dressing
10.6.2 Biologics
10.6.3 Traditional Burn Care Products
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Burkitt Lymphoma Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Burkitt Lymphoma Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Burkitt Lymphoma Therapeutics Market Size Forecast by Type
11.6.1 Advanced Dressing
11.6.2 Biologics
11.6.3 Traditional Burn Care Products
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Burkitt Lymphoma Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Burkitt Lymphoma Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Burkitt Lymphoma Therapeutics Market Size Forecast by Type
12.6.1 Advanced Dressing
12.6.2 Biologics
12.6.3 Traditional Burn Care Products
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Burkitt Lymphoma Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Burkitt Lymphoma Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Burkitt Lymphoma Therapeutics Market Size Forecast by Type
13.6.1 Advanced Dressing
13.6.2 Biologics
13.6.3 Traditional Burn Care Products
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Burkitt Lymphoma Therapeutics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Burkitt Lymphoma Therapeutics Market: Competitive Dashboard
14.2 Global Burkitt Lymphoma Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Takeda
14.3.2 Avita Medical
14.3.3 Smith＆Nephew
14.3.4 Coloplast Group
14.3.5 Systagenix Wound Management
14.3.6 MölnlyckeHealthCare
14.3.7 ConvaTec
14.3.8 Osiris Therapeutics
